News
-
-
-
-
-
PRESS RELEASE
EQS-Adhoc: Fielmann Group AG updates guidance for the 2026 financial year amid continued consumer uncertainty in Germany
Fielmann Group AG adjusts 2026 financial year guidance due to consumer uncertainty in Germany. Sales expected at €2.50bn to €2.55bn, with Adjusted EBITDA margin at 22% to 23% -
-
-
-
PRESS RELEASE
Total number of voting rights and capital / Information on the total number of voting rights and the number of shares making up the capital
Theraclion provides monthly update on total number of voting rights and shares. French MedTech company developing non-invasive alternative to surgery using focused ultrasound -